Neutralising antibodies to interferon beta in multiple sclerosis: analytical comparison between two different cytopathic assays

被引：0
|
作者：
Orpez, T.
Oliver, B.
Lopez-Gomez, C.
Mayorga, C.
Fernandez-Sanchez, V. E.
Alonso, A.
Luque, G.
Fernandez, O.
机构：
[1] Fdn IMABIS, Malaga, Spain
[2] Inst Neurosci Clin, Malaga, Spain
来源：
MULTIPLE SCLEROSIS | 2007年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S60 / S61
页数：2
相关论文
共 50 条
  • [21] Neutralising antibodies to interferon-beta-1b have no impact on clinical response in multiple sclerosis
    Goodin, D. S.
    Noronha, A.
    Hurwitz, B. J.
    MULTIPLE SCLEROSIS, 2006, 12 : S205 - S205
  • [22] Neutralising antibodies to interferon-β in the treatment of multiple sclerosis -: Cause for concern?
    Paszner, B
    Petkau, J
    Oger, J
    CNS DRUGS, 1999, 11 (03) : 225 - 243
  • [23] Fate of multiple sclerosis patients positive for neutralising antibodies towards interferon beta shifted to alternative treatments
    Malucchi, S
    Capobianco, M
    Gilli, F
    Marnetto, E
    Caldano, M
    Sala, A
    Bertolotto, A
    NEUROLOGICAL SCIENCES, 2005, 26 (Suppl 4) : S213 - S214
  • [24] Development of interferon beta-neutralising antibodies in multiple sclerosis—a systematic review and meta-analysis
    Karthik Govindappa
    Jean Sathish
    Kevin Park
    Jamie Kirkham
    Munir Pirmohamed
    European Journal of Clinical Pharmacology, 2015, 71 : 1287 - 1298
  • [25] Frequency and clinical aspect of neutralising antibodies to interferon-beta in a large cohort of multiple sclerosis patients
    Bucello, S.
    Liberatore, G.
    Moiola, L.
    Radaelli, M.
    Sala, A.
    Capobianco, M.
    Bertolotto, A.
    Martinelli, V.
    Comi, G.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S130 - S130
  • [26] In vivo bioactivity of interferon-beta in multiple sclerosis patients with neutralising antibodies is titre-dependent
    Sominanda, A.
    Hillert, J.
    Fogdell-Hahn, A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (01): : 57 - 62
  • [27] Neutralising Antibodies to Interferon-beta Therapy in Chinese Patients with Relapsing and Remitting Multiple Sclerosis.
    Ip, W. K.
    Lau, A. Y. L.
    Zhang, S.
    Au, C. C. K.
    Wong, W.
    Lau, K. K.
    Li, P.
    Chan, E. Y. T.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (03) : 416 - 417
  • [28] Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis
    Sorensen, PS
    Ross, C
    Clemmesen, KM
    Bendtzen, K
    Frederiksen, JL
    Jensen, K
    Kristensen, O
    Petersen, T
    Rasmussen, S
    Ravnborg, M
    Stenager, E
    Koch-Henriksen, N
    LANCET, 2003, 362 (9391): : 1184 - 1191
  • [29] Determination of interferon beta neutralizing antibodies in multiple sclerosis: Improvement of clinical sensitivity of a cytopathic effect assay
    Massart, Catherine
    Gibassier, Jacqueline
    de Seze, Jerome
    Debouverie, Marc
    Moreau, Thibault
    Pelletier, Jean
    Vermersch, Patrick
    Edan, Gilles
    CLINICA CHIMICA ACTA, 2008, 391 (1-2) : 98 - 101
  • [30] Multiple sclerosis patients lacking antibodies in cerebrospinal fluid are less likely to develop neutralising antibodies against interferon-beta
    Lundqvist, M.
    Greiner, E.
    Imrell, K.
    Hillert, J.
    Fogdell-Hahn, A.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S19 - S20
12345